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Received August 24, 2010; accepted November 30, 2010AbstractBackground: Obesity is a worldwide public health issue, and the prevalence of obesity is also increasing steadily in Taiwan. Obesity leads to
several chronic diseases. Often, impaired quality of life is a consequence of obesity. The aim of this study was to determine if body weight-loss
could improve health-related quality of life (HRQOL) in Taiwan.
Methods: The cutoff for obesity is bodymass index (BMI)¼ 27 as compared with 30 in US and Europe.We enrolled 67 participants with BMI 27
and more than one criterion of the metabolic syndrome, who underwent 3 months of body weight-loss intervention by diet control and regular
exercise. We performed anthropometric measurements and blood tests, and administered theWHOQOL-BREF questionnaire Taiwanese version to
assess HRQOL before and after the weight loss intervention. This is the first study using theWHOQOL-BREF to examine HRQOL in Taiwan. The
questionnaire included D1 physical, D2 psychological, D3 social relationships and D4 environmental domains; each was scored from 4 to 20.
Results: Obese subjects had lower D1 and D2 scores as compared with the Taiwan healthy population reference group at baseline. In this study,
38 participants completed the 3-month intervention program and 29 participants dropped out. Twenty-five participants reached the 5% of initial
BMI goal. Among them, significant statistical improvements were found both in medical comorbidities and in the four domains of the HRQOL
questionnaire.
Conclusion: Obesity can cause impaired HRQOL, which can be improved through BMI intervention. In addition to the benefits of biomedical
aspect, this could be an incentive goal for keeping body weight control.
Copyright  2011 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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The prevalence of obesity is increasing largely due to lifestyle
changes.1,2 Several metabolic abnormalities are associated with
obesity, including elevated blood pressure, hyperlipidemia, and
hyperglycemia.3 The concept of insulin resistance was first
proposed by Reaven as a pathophysiological construct,4,5 and in
1998, World Health Organization (WHO) coined the term
metabolic syndrome to represent several interrelated abnor-
malities that increase the risk for cardiovascular disease and
diabetes mellitus.6e8 The impact of metabolic syndrome on* Corresponding author. Dr. Hsiang-Ju Pan, Department of Family Medicine,
Kaohsiung Veterans General Hospital, 386, Ta-Chung 1st Road, Kaohsiung
813, Taiwan, ROC.
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doi:10.1016/j.jcma.2011.01.038physical health is well understood; as we all know, chronic
disease can further impaired the quality of life, the same
condition may occur in obesity, hence several measurement
instruments have been used to evaluate the quality of life in
obesity.9 In this study, the WHOQOL-BREF Taiwanese version
questionnaire was employed to assess the effects of body weight
control on the physical, psychological, social and environment
function in obese subjects. Our study aim was to confirm
whether this poor quality of life could be improved through body
weight loss.1.1. Epidemiology of metabolic syndrome in TaiwanIn Taiwan, the prevalence of obesity has increased steadily.
Using the criteria defined by the Department of Health inhinese Medical Association. All rights reserved.
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as BMI  27], the age-adjusted prevalences of obesity were
10.5% and 15.9% for men and 13.2% and 10.7% for women
from 1993e1996 to 2000e2001.10 The prevalence of meta-
bolic syndrome in the adult population in developed countries
is 22e39% and varies depending on the definition used and on
ethnicity.11 This syndrome has become increasingly common
in Taiwan. In Chuang et al’s hospital-based study, the preva-
lence of metabolic syndrome was 12.9% (15.5% in men and
10.5% in women, respectively) with the Asian criteria for
waist circumference.12 In a study in Kinmen, Taiwan,13 the
metabolic syndrome was present in 21.2% of the population
(where 17.7% of men and 23.8% of women). In a hospital-
based study in central Taiwan, the prevalence of metabolic
syndrome was 30.0% in men and 22.9% in women.141.2. Psychiatric consequencesSeveral recent reviews have disclosed that obesity is also
associated with an increased risk for psychiatric comorbidity,
stress, and impaired health-related quality of life (HRQOL)
based on physical, social, and psychological domains.15e17
For instance, in a study of 293 obese patients compared to
293 lean individuals, results revealed obesity was associated
with a significant lifetime major risk both for axis I
(OR ¼ 3.47, p < 0.001) and axis II disorders (OR ¼ 2.27,
p < 0.001). Obesity was also associated with significantly
lower measures of subjective quality of life. Comorbidity with
psychiatric axis I/II disorders, particularly among obese
patients, was associated with lower quality of life measures on
the WHOQOL-BREF questionnaire.18 Another study also
showed that an abnormally high BMI was associated with an
increased likelihood of having serious psychological distress,
independent of obesity-related comorbidities, lifestyle factors,
or emotional support.19e21
The global emergence of obesity and diabetes is as much an
economic issue as it is a health issue.22,23 The ever-growing
number of obesity cases not only increases the social burden but
also interferes with personal life. This is the first study to use the
WHOQOL-BREF questionnaire Taiwanese version to assess
quality of life in obese persons in Taiwan. We predicted that
body weight loss would lead to improvement in the HRQOL.
2. Methods2.1. SubjectsWe recruited obese individuals from Family Medicine Body
Weight Control Clinics of Kaohsiung Veterans General
Hospital from January 2008 till July 2008. Inclusion criteria
were a BMI  27 kg/m2 with more than one factor of the
metabolic syndrome criteria and between 20 and 65 years old.
To make sure the quality of life was not influenced because of
underlying disease, those patients with major systemic disease
and psychiatric disease history were excluded. At the initial
consultation, participants were screened for study eligibility
and informed consents were obtained. We enrolled 67participants, all of whom had central obesity according to Asian
WHO criteria. Among them, 39 were male and 28 were female.
The mean age was 40.3  10 years, mean body weight was
88.8 16.4 kg, and mean BMI was 32.4 4.0 kg/m2 (Table 1).2.2. ProcedureAll procedures were performed following 12 hours of
overnight fasting. The participants came to the laboratory at
9 AM and wore a hospital gown and no shoes. They completed
a pre-intervention checkup, including anthropometric
measurements, vital signs, and the WHOQOL-BREF ques-
tionnaire Taiwanese version. A fasting blood sample was
obtained to perform laboratory tests. All staff were trained and
certified for doing the measurements. Participants signed an
IRB approved consent.2.3. Anthropometric measurementsBody weight was measured with a Tanita TBF-410 Pro body
composition analyzer, which records body weight to the nearest
0.1 kg and body fat to 0.1% based on bioimpedance analysis. A
calibrated digital scale (Super-View HW2020) was used to
measure body height to the nearest 0.1 cm. BMI was then
calculated from weight and height. The neck, upper forearm,
waist, hip, thigh, and calf circumference were measured. The
circumferences of the neck, upper forearm, and calf were
measured at the mid-point, and the thigh at the groin. Waist
circumference was measured between the lower rib margin and
the iliac crest, with participants standing with their heels
together.242.4. Body compositionBody fat was also measured with dual-energy X-rays
(DXA, QDR4500A; Hologic Delphi, Bedford, MA, USA)
using DXA software version 8.21 (Hologic). All systems were
routinely calibrated, and quality control measures were fol-
lowed as recommended by the respective manufacturers.2.5. Blood testsSerum glucose, glycated hemoglobin(HbA1c), glutamcic
oxaloacetic transaminase(GOT), glutamic pyruvic trans-
aminase(GPT), total cholesterol, high-density lipoprotein
(HDL), low-density lipoprotein (LDL), triglyceride, creatinine,
and uric acid were measured by the hospital chemistry lab.
Insulin was measured with ELISA (IMMULITE 2000) in the
endocrine laboratory.2.6. HRQOLWe used the self-administered WHOQOL-BREF question-
naire Taiwanese version to assess HRQOL. The internal
consistency (Cronbach a) coefficients ranged from 0.70 to 0.77
for the four domains. The questionnaire has good test-retest
reliability coefficients over intervals of 2e4 weeks, which
Table 1
Baseline characteristics of 67 obese participants and the comparison between completers and drop-outsa
Min Max Average Drop-out (n ¼ 29) Completer (n ¼ 38) p
Age (yr) 21.0 63.0 40.3  10.0 41.4  9.8 39.6  10.3 0.447
Weight (kg) 64.2 126.5 88.8  16.4 89.0  17.0 88.6  16.1 0.911
Height (cm) 149.5 189.6 165.0  9.0 166.5  10.1 164.0  8.1 0.257
BMI (kg/m2) 27.4 45.7 32.4  4.0 31.9  3.6 32.8  4.4 0.348
Tanita body fat (%) 23.6 63.1 39.7  9.1 39.7  9.5 39.7  8.9 0.987
DXA whole body fat (%) 19.8 50.2 34.5  6.8 34.4  7.1 34.6  6.7 0.940
DXA trunk body fat (%) 21.5 50.2 36.5  6.3 36.0  6.6 36.9  6.1 0.555
Neck circum. (cm) 34.0 50.5 40.1  3.6 39.8  3.7 40.4  3.5 0.522
Upper forearm circum. (cm) 28.5 43.5 34.8  3.4 34.6  3.4 35.1  3.4 0.585
Waist (cm) 83.0 134.0 101.1  10.1 100.2  9.3 100.2  10.7 0.417
Hip (cm) 95.5 129.0 108.7  8.4 109.2  8.1 108.3  8.7 0.669
Thigh (cm) 43.0 71.0 56.2  5.6 56.4  5.5 56.1  5.8 0.850
Calf (cm) 34.0 49.0 40.6  3.3 40.5  3.2 40.7  3.4 0.784
SBP (mmHg) 100.0 190.0 133.4  20.0 132.1  21.0 134.4  19.6 0.657
DBP (mmHg) 60.0 120.0 91.2  12.1 91.4  11.6 90.9  12.7 0.869
GOT (mg/dL) 13.0 114.0 30.6  16.9 31.8  20.9 29.7  13.4 0.612
GPT (mg/fL) 13.0 413.0 56.8  59.6 64.1  79.7 51.1  32.1 0.364
Uric acid (mg/dL) 4.1 11.7 7.0  1.7 6.6  1.7 7.3  1.7 0.123
Creatinine (mg/dL) 0.6 1.5 1.0  0.2 1.0  0.2 1.0  0.2 0.536
T. CHOL (mg/dL) 117.0 305.0 200.7  38.8 199.9  35.7 201.4  41.5 0.882
HDL (mg/dL) 24.0 62.0 40.4  9.1 41.2  10.8 39.9  7.8 0.546
LDL (mg/dL) 49.0 201.0 116.1  31.8 111.2  28.5 119.9  34.0 0.275
TG (mg/dL) 47.0 1243.0 214.2  208.0 238.9  262.5 195.3  155.5 0.400
Glucose (mg/dL) 68.0 243.0 110.0  35.4 110.2  36.2 109.8  35.3 0.967
Insulin (U/mL) 3.9 45.5 17.6  8.7 18.3  9.7 17.0  8.1 0.536
IR (HOMA index) 0.0 74.0 5.9  9.2 5.2  4.5 6.4  11.7 0.599
HbA1c (%) 4.7 14.4 6.5  1.8 6.8  2.4 6.2  1.2 0.264
Sat. of HRQOL 5.0 90.0 62.5  15.8 64.6  13.3 60.9  17.5 0.353
Sat. of BHRQOL 5.0 95.0 67.5  16.9 65.2  17.9 69.2  16.2 0.345
D1 9.1 18.9 13.77  2.02 13.83  2.16 13.71  1.94 0.815
D2 5.3 19.3 12.62  2.43 13.03  2.65 12.30  2.22 0.221
D3 7.0 19.0 13.82  2.22 13.86  2.49 13.79  2.03 0.896
D4 8.9 17.3 13.69  1.74 13.67  1.45 13.71  1.96 0.932
a Data are presented as n or mean  standard deviation.
Independent samples test was used to compare characteristics of completers and drop-outs.
BMI ¼ body mass index; D1 ¼ physical domain; D2 ¼ psychological domain; D3 ¼ social relationships domain; D4 ¼ environmental domain; DBP ¼ diastolic
blood pressure; DXA ¼ dual energy X-ray absorptiometry; GOT ¼ glutamcic oxaloacetic transaminase; GPT ¼ glutamic pyruvic transaminase; HbA1c ¼ glycated
hemoglobin; HDL ¼ high-density lipoprotein; IR ¼ insulin resistance; LDL ¼ low-density lipoprotein; Sat. of BHRQOL ¼ satisfied with health related quality of
life before body weight gain; Sat. of HRQOL ¼ satisfied with health related quality of life; SBP ¼ systolic blood pressure; T. CHOL ¼ total cholesterol;
TG ¼ triglyceride.
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level (all p < 0.01). Content validity coefficients were in the
range of 0.53e0.78 for item-domain correlations and
0.51e0.64 for inter-domain correlations (all p < 0.01).25
The WHOQOL-BREF questionnaire Taiwanese version has
28 items, consisting of 26 standard items from the original
WHOQOL-BREF and two newly developed Taiwanese
items.25,26 One item was included in the social relationships
domain (“Do you feel respected by others?”). The other item
was contained in the environmental domain (“Are you usually
able to get the things you like to eat?”). These 28 items were
classified into four domains: D1 physical domain (7 items),
D2 psychological domain (6 items), D3 social relationships
domain (5 items) and D4 environmental domain (10 items). The
domain scores were calculated by multiplying the mean of all
item scores by a factor of 4, thus scores ranged from 4 to 20.
Higher scores indicated better quality of life. Another two
questions were added on to assess satisfaction of HRQOL. Thefirst was “How satisfied are you with your HRQOL?” The
second was “How satisfied were you with your HRQOL before
your body weight gain?” The score ranged from 0, the worst, to
100, the best. The norms of healthy population reference group
for the WHOQOL-BREF questionnaire Taiwanese version
were obtained by using the data from the 2001 National Health
Interview Survey (NHIS; Atlanta, GA, USA) in Taiwan.2.7. Body weight loss intervention programThe dietary prescription was for reduction of daily food
intake by 500 kcal and 30 minutes of aerobic exercise 5 days
a week. Participants returned to the clinic every 2 weeks and
body weight, waist circumference and blood pressure were
measured. They met with a physician for a 20 minutes nutri-
tional and exercise consultation. The intervention program was
for 3 months, at which time there was a post-intervention
assessment repeating the same tests as at the beginning.
Table 2
The changes between pre- and post-intervention in completers (n¼38)
Mean  SD 95% CI p
Lower Upper
Weight (kg) 6.9  5.2 5.2 8.6 0.000a
BMI (kg/m2) 2.5  1.8 1.9 3.1 0.000a
Tanita body fat (%) 4.6  5.0 3.0 6.3 0.000a
DXA whole body fat (%) 2.1  2.6 1.2 2.9 0.000a
DXA trunk body fat (%) 2.6  3.4 1.5 3.8 0.000a
Neck circum. (cm) 1.5  1.2 1.1 1.8 0.000a
Upper forearm circum. (cm) 1.8  1.6 1.2 2.3 0.000a
Waist (cm) 5.9  4.7 4.4 7.5 0.000a
Hip (cm) 4.1  5.0 2.4 5.7 0.000a
Thigh (cm) 0.9  3.6 0.3 2.1 0.141
Calf (cm) 1.0  1.3 0.6 1.4 0.000a
SBP (mmHg) 7.0  18.0 1.1 12.9 0.022
DBP (mmHg) 6.1  11.3 2.4 9.8 0.001
GOT (mg/dL) 5.4  12.4 1.3 9.4 0.011
GPT (mg/fL) 18.3  28.8 8.8 27.7 0.000a
Uric acid (mg/dL) 0.5  1.7 0.0 1.1 0.069
Creatinine (mg/dL) 0.0  0.1 0.1 0.0 0.644
T. CHOL (mg/dL) 15.9  32.8 5.1 26.7 0.005a
HDL (mg/dL) 1.1  4.5 2.6 0.4 0.138
LDL (mg/dL) 15.4  25.9 6.8 23.9 0.001a
TG (mg/dL) 47.0  125.7 5.7 88.4 0.027a
Glucose (mg/dL) 1.1  27.5 10.2 7.9 0.801
Insulin (U/mL) 1.7  6.1 0.3 3.7 0.091
IR (HOMA index) 0.2  2.1 0.5 0.9 0.572
HBA1c (%) 0.1  0.5 0.1 0.2 0.530
Sat. of HRQOL 7.3  14.6 12.1 2.4 0.040a
Sat. of BHRQOL 0.5  12.0 4.4 3.4 0.798
D1 0.7  1.7 1.2 0.1 0.023a
D2 0.9  1.7 1.5 0.3 0.003a
D3 0.7  1.4 1.2 0.2 0.040a
D4 0.5  1.2 0.9 0.1 0.012a
a Two-tailed p  0.05 with statistical significance, paired-samples t test.
Abbreviations as in Table 1.
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HRQOL scores of our participants with the healthy population
reference group mean. Independent-samples t test was used to
compare the demographics between the participants who
completed the study and those who dropped out. Paired-Table 3
WHOQOL-BREF questionnaire Taiwanese version score compared with norm ref
Baseline (n ¼ 67) Mean  SD p
D1 13.77  2.02 0.000a
D2 12.62  2.43 0.000a
D3 13.82  2.22 0.146
D4 213.69  1.74 0.094
 5%BWL (n ¼ 25) Pre-intervention p
D1 13.87  1.86 0.001a
D2 12.53  1.69 0.652
D3 13.92  1.69 0.381
D4 13.94  1.87 0.116
a Two-tailed p  0.05 with statistical significance.
One-sample t test compared with healthy population reference group, the norms wesamples t test was used to compare the data pre- and post-
intervention. Two-tailed p  0.05 was required for statistical
significance (SPSS).
3. Results
Of the 67 participants, 38 (56.7%) participants completed
the 3-month-intervention and had the post-intervention
assessment; 29 (43.3%) participants dropped out. However,
there were no significant baseline demographic differences
noticed between completers and drop-outs (Table 1). As
shown in Table 2, on average, there were significant changes
from pre- to post-intervention in body weight, BMI, body fat,
and all the circumferences measurements except thigh. For the
blood tests, statistical changes were also found in GOT, GPT,
total cholesterol, high-density lipoprotein cholesterol (HDL),
low-density lipoprotein (LDL), and triglycerides. Of these, 25
(65.8%) participants reached or exceeded the 5% of initial
body weight loss goal.
The baseline scores of quality of in the 67 participants were
relatively lower compared with those of the healthy population
reference: D1 physical domain [13.77  2.02 vs. 15.31  1.93,
p < 0.001; 95% confidence interval (CI) of the difference,
2.04 to 1.05], D2 psychological domain (12.62  2.43 vs.
13.80  2.19, p < 0.001; 95% CI of the difference, 1.78 to
0.59), D3 social relationships domain (13.82  2.22 vs.
14.22  2.22, p ¼ 0.146; 95% CI of the difference, 0.94 to
0.14), D4 environmental domain (13.69  1.74 vs.
13.33  2.05, p ¼ 0.094; 95% CI of the difference, 0.06 to
0.79) (Table 3). More significant improvements in thigh
circumference, uric acid, fasting sugar, insulin and insulin
resistance were found in the 25-case group that lost 5% of
initial body weight (Table 4). No matter how much body
weight was lost, the four domain scores’ improvement was
found in both groups, but only those who lost 5% of initial
body weight group showed a significant change.
4. Discussion
The National Heart, Lung and Blood Institute (NHLBI)
issued clinical guidelines about successful body weighterences
Post-intervention p
14.63  1.59 0.043
13.44  1.73 0.309
14.56  1.78 0.349
14.42  1.60 0.002a
re D1: 15.31  1.93, D2: 13.80  2.19, D3: 14.22  2.05, D4: 13.33  2.05.
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body weight in overweight and obese adults appears to reduce
various chronic disease risk factors (e.g., hypertension,
hyperlipidemia, hyperglycemia) and may decrease morbidity
and mortality.28 One surprising finding in our study was that
5% of initial body weight loss was good enough to improve
liver function, total cholesterol, HDL-cholesterol, LDL-
cholesterol, blood pressure, glycemic control, and a concomi-
tant improvement in HRQOL. In addition, more anthropo-
metric reductions were also found in the neck, upper forearm,
waist, hip, thigh, and calf circumference. Why does as little as
5% of initial body weight loss result in these benefits? One
interpretation is that this may be due to an ethnic difference;
further investigation in future studies is needed.
With conventional life style intervention, ideal body weight
loss is achievable. The Diabetes Prevention Program have
demonstrated that modest weight loss achieved by lifestyle
changes (diet and exercise) can significantly reduce the risk of
developing type 2 diabetes in obese patients with impaired
glucose tolerance.29 Evidence-based studies showed weight-
loss strategies using dietary, physical activity, or behavioralTable 4
The changes between pre- and post-intervention in different body weight loss
group
(pre - post-) intervention
Body weight loss group  5% (n ¼ 25) < 5% (n ¼ 13)
Mean  SD p Mean  SD p
Weight (kg) 9.5  4.6 0.000a 1.8  1.1 0.000a
BMI (kg/m2) 3.5  1.4 0.000a 0.7  0.4 0.000a
Tanita body fat (%) 5.7  3.6 0.000a 2.7  6.6 0.172
DXA whole body fat (%) 3.2  2.4 0.000a 0.1  1.2 0.852
DXA trunk body fat (%) 3.7  3.5 0.000a 0.2  1.6 0.646
Neck circum. (cm) 1.9  1.1 0.000a 0.7  0.8 0.008a
Upper forearm circum. (cm) 2.5  1.6 0.000a 0.5  0.9 0.047a
Waist (cm) 8.1  4.2 0.000a 1.9  2.0 0.005a
Hip (cm) 5.9  4.9 0.000a 0.4  2.7 0.568
Thigh (cm) 1.7  4.0 0.049a 0.6  1.9 0.257
Calf (cm) 1.2  1.2 0.000a 0.5  1.5 0.253
SBP (mmHg) 11.0  17.7 0.005a 0.7  16.6 0.883
DBP (mmHg) 5.4  11.8 0.031a 7.5  10.6 0.024a
GOT (mg/dL) 7.3  13.8 0.014a 1.7  8.3 0.477
GPT (mg/fL) 24.6  32.8 0.001a 6.2  12.8 0.105
Uric acid (mg/dL) 0.9  1.8 0.018a 0.2  1.5 0.681
Creatinine (mg/dL) 0.0  0.1 1.000 0.0  02 0.538
T. CHOL (mg/dL) 23.7  28.5 0.000a 0.8  36.3 0.934
HDL (mg/dL) 2.6  4.5 0.008a 1.8  3.0 0.053
LDL (mg/dL) 19.6  22.8 0.000a 7.3  30.5 0.405
TG (mg/dL) 49.9  124.1 0.062 41.9  128.9 0.264
Glucose (mg/dL) 9.08  12.5 0.001a 20.8  37.2 0.067
Insulin (U/mL) 3.4  6.0 0.008a 1.6  5.1 0.291
IR (HOMA index) 0.9  1.7 0.020a 1.1  2.1 0.079
HBA1C (%) 0.1  0.4 0.068 0.1  0.7 0.582
Sat. of HRQOL 6.2  14.9 0.048a 9.2  14.5 0.041
Sat. of BHRQOL 0.6  9.3 0.752 2.6  16.1 0.569
D1 0.8  1.9 0.006a 0.5  1.3 0.211
D2 0.9  1.7 0.015a 0.9  1.9 0.101
D3 0.6  1.4 0.036a 0.8  1.5 0.059
D4 0.5  1.0 0.027a 0.5  1.4 0.212
a Two-tailed p  0.05 with statistical significance, paired-samples t test.
Abbreviations as in Table 1.interventions produced significant improvements in weight
among persons with pre-diabetes, and a significant decrease in
diabetes incidence.30 Besides the physiological benefits,
weight-loss also promotes HRQOL as showed in one study
which enrolled overweight adults diagnosed as having type 2
diabetes who experienced significant improvement in HRQOL
by weight-loss strategies.31
Several studies have brought awareness to the psycholog-
ical comorbidity in obesity,18 and a significant improvement in
quality of life after weight-loss was also documented, espe-
cially in studies that investigated the effects of gastric bypass
surgery where there is a dramatic body weight loss.32 Table 3
depicts the significantly lower baseline scores of quality of life
(D1, D2) in our study participants as compared with a healthy
population reference group; but no more difference was
noticed after 3 months of body weight loss intervention.
The WHOQOL-BREF questionnaire Taiwanese version is
an established and widely used tool to measure HRQOL in
Taiwan in different disease groups, but it had not been applied to
obesity before. It was used in this study to assess the aspects of
physical and spiritual well-being of obesity. The D1 physical
domain includes the extent of physical pain, discomfort, energy,
fatigue and quality of sleep. In Taiwan, excess weight is related
to worse physical condition.33 Among these ailments, muscu-
loskeletal problems are very common, affecting up to 20% of
adults,34 which have an overall economic impact that can be
measured by the use of health care and social care resources,
and by work disability.35 Obese patients tend to have muscu-
loskeletal problems, such as a strong association between knee
osteoarthritis and obesity, which has been revealed in several
studies.36 Furthermore, in the Framingham longitudinal study,
high BMI predicted development of knee osteoarthritis in later
life.37 However, this condition could be improved by weight
loss; the benefits of weight control in reducing the occurrence
and severity of knee osteoarthritis were documented in previous
studies.38 Apart from physical discomfort, sleep apnea is also
one of the comorbidities of obesity; it is an effect of the cyto-
kines released from fat cells.39 Hence, daytime fatigue and
lower energy are easily found in obese patients. These could
explain the cause of the lower D1 physical domain baseline
score in our study subjects. The D2 psychological domain
includes the extent of positive and negative feelings, thinking,
self-esteem, body image and spirit. Hence, it’s reasonable that
the D2 score improved along with the body weight loss.
A particularly surprising finding from the study was that the
25 participants with  5% of initial body weight loss had
raised D4 scores as compared with healthy population refer-
ence group, despite no difference in pre-intervention condition
(Table 3). The D4 environment domain evaluates the following
aspects: safety, opportunity to take leisure time, financial
resources, the convenience of getting information and medical
service, home environment and transportation. This suggested
that body weight loss somehow associated with the satisfac-
tion in one’s environment.
Among the assessment questions focusing on satisfaction of
HRQOL, the first, “How satisfied are you with your HRQOL?”,
had an initial score of 61.4 in 38 participants and after the
174 H.-J. Pan et al. / Journal of the Chinese Medical Association 74 (2011) 169e1753-month intervention the score increased to 68.7 (7.3 14.7 ,
p ¼ 0.004). With regard to “How satisfied were you with your
HRQOL before your body weight gain?”, in the same group of
38 participants, the initial score was 68.8 and at the end of the 3-
month intervention the scorewas 69.3 (0.5 12.0, p¼ 0.798).
This validates the consistency which with participants perceive
themselves before weight gain.
The recent WHO report, “Preventing Chronic Diseases: A
vital investment”, highlights the need for global action to
address the major risks associated with chronic disease
worldwide.40 The optimal management is continuous healthy
life style; however, controlling body weight is a daunting task
and long journey, with some loss of perseverance in the
course, just like our drop-out study group of 29 participants.
The high drop-out rate in this study reflects an important issue,
the difficulty of behavioral change. How can we encourage
people to keep healthy life style in today’s parenting obeso-
genic environment is a big challenge. Apart from the physi-
ological benefits after weight loss, further improvement in
quality of life may be an incentive to obese patients to keep
implementing a body weight control regimen.
The limitations of the study were both the small number of
participants and short study period. In view of chronic disease
management, obesity-control should be followed up for
a longer time period, and follow-up of study participants will
continue.
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